GF Fund Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
KCM
GF Fund Management's SNDX Position: Q3 2026 in Review
GF Fund Management increased its Syndax Pharmaceuticals (SNDX) stake by 8.8% in Q3 2026, buying an estimated $3.33K and bringing the position to 2,033 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #427.
GF Fund Management first reported a position in SNDX in Q4 2024 and has held it in 8 quarters since. The position peaked at $45.6K in Q1 2026. 237 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.
- GF Fund Management held 2,033 shares of Syndax Pharmaceuticals worth $38.2K as of Q3 2026.
- GF Fund Management bought 165 Syndax Pharmaceuticals shares in Q3 2026, an estimated $3.33K.
- Syndax Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #427 holding.
- GF Fund Management first reported a position in Syndax Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's Syndax Pharmaceuticals position peaked at $45.6K in Q1 2026.
- 237 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.